XBiotech Inc. (XBIT)

USD 6.09

(-9.64%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - 4.01 Million 18.39 Million 43.99 Million - -
Cost of Revenue 1.74 Million 651 Thousand 5.82 Million 34.54 Million 2.36 Million 2.43 Million
Gross Profit -1.74 Million 3.35 Million 12.57 Million 9.44 Million -2.36 Million -2.43 Million
Operating Expenses 37.51 Million 37.84 Million 37.65 Million 27.72 Million 31.23 Million 20.99 Million
Selling, General and Administrative Expenses 4.66 Million 6.3 Million 9.38 Million 18.19 Million 7.14 Million 5.26 Million
Research and Development Expenses 32.84 Million 31.54 Million 28.26 Million 9.52 Million 24.09 Million 15.72 Million
Other Expenses - -121 Thousand -132 Thousand -503 Thousand 750.01 Million 4000.00
Cost and Expenses 37.51 Million 38.5 Million 43.47 Million 62.27 Million 31.23 Million 20.99 Million
Operating Income -37.51 Million -34.49 Million -25.08 Million -18.27 Million -31.23 Million -20.99 Million
Interest Expense - - - - - -
Income Tax Expense 244 Thousand -688 Thousand -8.04 Million -1.6 Million 49.82 Million -144 Thousand
Earnings before Tax -24.31 Million -33.58 Million -25.45 Million -12.82 Million 718.45 Million -21.13 Million
Net Income -24.55 Million -32.9 Million -17.41 Million -11.22 Million 668.62 Million -21.13 Million
Earnings Per Share Basic -0.81 -1.08 -0.58 -0.36 17.17 -0.59
Earnings Per Share Diluted -0.81 -1.08 -0.58 -0.36 14.44 -0.59
Weighted Average Shares Outstanding 30.31 Million 30.43 Million 30.04 Million 30.82 Million 38.94 Million 35.8 Million
Weighted Average Shares Outstanding (Diluted) 30.43 Million 30.43 Million 30.04 Million 30.82 Million 46.31 Million 35.8 Million
Gross Margin - 0.84 0.68 0.21 - -
EBIT Margin - -7.25 -1.18 -0.44 - -
Profit Margin - -8.20 -0.95 -0.26 - -
EBITDA -35.76 Million -31.87 Million -22.43 Million -16.03 Million -28.87 Million -18.7 Million
Earnings Before Tax Margin - -8.60 -1.36 -0.42 - -

Income Statement Charts